Viridien Announces its First Quarter 2025 Financial Results on Tuesday, April 29, 2025, after Market Close
Werte in diesem Artikel
Paris, France – March 27, 2025
First Quarter 2025 financial results and conference call
Viridien will announce its first quarter 2025 financial results on Tuesday, April 29, after market close.
- The press release and the presentation will be made available on our website www.viridiengroup.com at 5.45 pm (CET).
- An English language analysts conference call is scheduled the same day at 6.00 pm (CET).
Participants should register for the call here to receive a dial-in number and code or participate in the live webcast from here.
A replay of the conference call will be made available the day after for a period of 12 months in audio format on the Company's website www.viridiengroup.com.
Erratum: Please note that the Q4 & FY 2024 press release and presentation, published on February 27, 2025 have been amended. The new versions are available on our website :
About Viridien:
Viridien (www.viridiengroup.com) is an advanced technology, digital and Earth data company that pushes the boundaries of science for a more prosperous and sustainable future. With our ingenuity, drive and deep curiosity we discover new insights, innovations, and solutions that efficiently and responsibly resolve complex natural resource, digital, energy transition and infrastructure challenges. Viridien employs around 3,400 people worldwide and is listed as VIRI on the Euronext Paris SA (ISIN: FR001400PVN6).
Contacts
Investor Relations Jean-Baptiste Roussille Tel: + 33 6 14 51 09 88 E-Mail: jean-baptiste.roussille@viridiengroup.com |
Attachment

Ausgewählte Hebelprodukte auf Viridien
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Viridien
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Viridien
Analysen zu Viridien
Keine Analysen gefunden.